inositol and semaglutide together with Semaglutide: Safety & Supplement Timing Myo-inositol and GLP-1 weight loss

Environ Health Perspect 117:757762

Cardiometabolic outcome trials Prospective study of older adults (mean age 68 years) using liraglutide 3 mg once daily for 24 weeks found improved body composition with reductions in central fat mass, and preserved muscular performance [86, 87], explained by increased myogenesis in myoblasts [88], and the recruitment of skeletal muscle microvasculature [89]

The rationale is that weight loss beyond 15% often produces clinically meaningful improvements in joint symptoms, and retatrutide consistently crosses that threshold at moderate doses

Sections were stained with hematoxylin and eosin (H&E), wheat germ agglutinin (FITC-conjugated, Merck Life Science Oy, UK) and Picro-Sirius red (Abcam, # ab245887) to measure cell size and cardiac fibrosis level in the LV free wall at the level of the papillary muscles

Patients should never increase their dose more rapidly than recommended, as this significantly increases the risk of gastrointestinal side effects